Synapse

← Pneumonia

Papers in Pneumonia

Page 1 · newest first

  1. Air pollution is associated with a distinct pathogen spectrum in community-acquired pneumonia: a prospective multicentre cohort studyPneumonia · 2026
  2. Respiratory pathogens across rural populations: general practice patients with community-acquired pneumonia, residents, and goat farmersPneumonia · 2026
  3. Trends in all-cause pneumonia and influenza hospitalization incidence by coding position – a study of US healthcare claims, 2014–2023Pneumonia · 2026
  4. Community-acquired Haemophilus influenzae pneumonia in people living with HIV: a 30-year propensity score–matched cohort studyPneumonia · 2026
  5. Healthcare resource utilization and cost of invasive pneumococcal disease, pneumonia, and acute otitis media in commercially and medicaid-insured children by risk group in the United States, 2018 to 2023Pneumonia · 2026
  6. A clinician’s guide to corticosteroid therapy in pneumonia and critical illness: agent selection, dosing, monitoring, and interactionsPneumonia · 2026
  7. Nasopharyngeal microbiota profiles and lytA-PCR status in adult pneumococcal pneumonia: distinct microbial communities and diagnostic implicationsPneumonia · 2026
  8. Development and internal validation of a Viremia-Integrated Risk Assessment (VIRA score) for predicting mortality at diagnosis of COVID-19 pneumoniaPneumonia · 2026
  9. Pneumococcal pneumonia in adults – re-emergence of vaccine serotypes: a prospective multicenter cohort study in Germany, 2020–2023Pneumonia · 2026
  10. Antibiotic non-susceptibility associated serotypes of invasive pneumococcal disease - a nationwide population study from Switzerland, 2012–2022Pneumonia · 2026
  11. Corticosteroids in immunocompromised ICU patients with pneumonia: risks, evidence, and clinical practicePneumonia · 2026
  12. A multicentre case-control study about effectiveness of pneumococcal vaccination against pneumonia hospitalization in at-risk adultsPneumonia · 2026
  13. ARDS and corticosteroids: beyond COVID-19Pneumonia · 2026
  14. Pneumonia as a predictor of diabetes mellitus and coronary heart disease: a national cohort studyPneumonia · 2026
  15. The heterogeneous treatment effect of adjuvant therapy with corticosteroids in patients with Community-Acquired Pneumonia: a reviewPneumonia · 2026
  16. Health disparities in the burden of pneumococcal disease in US adultsPneumonia · 2026
  17. Eosinopenia and prognosis in severe community-acquired pneumoniaPneumonia · 2026
  18. Prognosis of clinical pneumonia in undernourished children in rural GambiaPneumonia · 2026
  19. The role of corticosteroids in severe viral pneumonia: lessons from COVID-19 and influenzaPneumonia · 2026
  20. Biomarker-guided use of corticosteroids in pneumoniaPneumonia · 2026
  21. Corticosteroids in severe community-acquired pneumonia: friend, foe or both?Pneumonia · 2026
  22. Evaluation of PSI, CURB-65, and CRB-65 as prognostic tools in hospitalized immunocompetent patients with pneumonia: real-world outcomes from internal medicine wardsPneumonia · 2026
  23. Diagnostic BioFire® FilmArray® Pneumonia Panel Plus versus standard microbial culture in bronchiectasis exacerbationsPneumonia · 2026
  24. Invasive pulmonary aspergillosis in the ICU: the corticosteroid linkPneumonia · 2026
  25. Influence of area-level social vulnerability on all-cause pneumonia, all-cause acute otitis media, and invasive pneumococcal disease incidence among Medicaid-enrolled childrenPneumonia · 2025
  26. Investigating risk factors for methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in community acquired pneumonia: a model for using only electronic data capturePneumonia · 2025
  27. Corticosteroids and hospital-acquired pneumoniaPneumonia · 2025
  28. Pneumocystis pneumonia in older non-HIV-infected patients: a French, multicentre, retrospective, cohort studyPneumonia · 2025
  29. Immunosuppressed patients with COVID-19 pneumonia in ICU: clinical characteristics and factors influencing outcomesPneumonia · 2025
  30. Individualized treatment rule for early steroid use in hospitalized patients with community acquired pneumonia: a cohort studyPneumonia · 2025
  31. Pneumococcal carriage and disease in adults hospitalised with community-acquired pneumonia in Mongolia: prospective pneumonia surveillance program (2019–2022)Pneumonia · 2025
  32. Time to death and its predictors among under-five children with acute pneumonia: a Bayesian parametric survival analysisPneumonia · 2025
  33. Existence and relevance of fulminant severe community-acquired pneumoniaPneumonia · 2025
  34. Prevalence of pneumococcal carriage and risk factors for pneumonia and carriage among under-5 children in Malaysia: findings from the MY-Pneumo studyPneumonia · 2025
  35. Identification of age-group reservoirs for persistent vaccine-type pneumococcal carriage in rural GambiaPneumonia · 2025
  36. Corticosteroids in non-viral acute respiratory distress syndrome (ARDS): recommendations outpace evidence – a concise reviewPneumonia · 2025
  37. Assessing the prevalence and the underdiagnosis of aspiration pneumonia among older hospitalized patients with community-acquired pneumonia using an artificial intelligence algorithmPneumonia · 2025
  38. Changes in carriage and serotype diversity of Streptococcus pneumoniae and other respiratory pathobionts in the UK between pre-PCV13 (2006-10), early-PCV13 (2010-12) and late-PCV13 (2012-23) periodsPneumonia · 2025
  39. Microbial profiling of community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease: a comprehensive molecular diagnostics studyPneumonia · 2025
  40. Clinical features and prognosis of severe legionnaires’ disease requiring intensive care unit admission: a multicentric retrospective cohort studyPneumonia · 2025
  41. Test and treat—impact of microbiological testing on antibiotic prescribing for Legionnaires’ disease in Switzerland: results of the multicentre SwissLEGIO studyPneumonia · 2025
  42. Organizing pneumonia in hospitalized COVID-19 patients: risk factors and long-term outcomesPneumonia · 2025
  43. RSV: an overview of infection in adultsPneumonia · 2025
  44. Are presentations of thoracic CT performed on admission to the ICU associated with mortality at day-90 in COVID-19 related ARDS?Pneumonia · 2025
  45. Chest tube drainage versus repeated therapeutic thoracentesis for the management of pleural infections: a retrospective multicentre propensity-matched studyPneumonia · 2025
  46. Chest drainage or repeated thoracentesis for pleural infections: a clinical dilemmaPneumonia · 2025
  47. Respiratory dysbiosis as prognostic biomarker of disease severity for adults with community-acquired pneumonia requiring mechanical ventilationSHILAP Revista de lepidopterología · 2025
  48. Changes in the incidence, viral coinfection pattern and outcomes of pneumococcal hospitalizations during and after the COVID-19 pandemicPneumonia · 2025
  49. Prevention of respiratory syncytial virus disease across the lifespan in ItalyPneumonia · 2025
  50. High incidence of pneumonia cases observed in children seen in general practice consultations during the 2023–2024 season, FrancePneumonia · 2025